ClinicalThought

Share

Program Content

Activities

  • NSCLC Biomarkers 2020
    New Developments in NSCLC Targeted Therapy: Where We Are Heading in 2020
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: February 28, 2020

  • CNS Mets in NSCLC
    How I Manage CNS Metastases and Leptomeningeal Carcinomatosis in NSCLC
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 28, 2020

  • Selpercatinib in <i>RET</i>+ NSCLC
    My Take on the Recent Approval of Selpercatinib for RET Fusion–Positive NSCLC
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 25, 2020

  • T-DXd for <em>HER2</em>mut NSCLC
    Trastuzumab Deruxtecan: An Emerging Option for HER2-Mutated NSCLC
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 22, 2020

Faculty

cover img faculity

Todd M. Bauer, MD

Senior Investigator, Greco-Hainsworth Centers for Research
Tennessee Oncology, PLLC
Nashville, Tennessee

cover img faculity

Lyudmila Bazhenova, MD

Associate Clinical Professor of Medicine
Division of Hematology-Oncology
University of California, San Diego
Medical Director, UC San Diego Moores Cancer Center Infusion Center
San Diego, California

cover img faculity

Edward S. Kim, MD

Chief, Section of Head and Neck Medical Oncology
Associate Professor, Thoracic/Head and Neck Medical Oncology
University of Texas M. D. Anderson Cancer Center
Houston, Texas

cover img faculity

Vamsidhar Velcheti, MD

Professor of Medicine
NYU Grossman School of Medicine
Medical Director
Thoracic Oncology Program
Laura and Isaac Perlmutter Cancer Center
An NCI-designated Comprehensive Cancer Center
New York, New York 

Provided by

ProCE Banner